CAPP-Seq, developed by SCI members Ash Alizadeh, MD, PhD and Max Diehn, MD, PhD, is a method to sensitively and specifically detect circulating tumor DNA in the blood using next-generation sequencing technologies. Circulating tumor DNA can be informative for telling whether a treatment is working and to help select the next therapy if a treatment is not working. #cancer #cancerresearch #science
Learn more about circulating tumor DNA: [ Ссылка ]
Learn more about the Stanford Cancer Institute: [ Ссылка ]
Follow the Stanford Cancer Institute
LinkedIn: [ Ссылка ]
Twitter: [ Ссылка ]
Subscribe to the Stanford Cancer Institute: [ Ссылка ]
